Source document or public record

FDA 510(k) K221420 — AlphaID™ At Home Genetic Health Risk Service

FDA 510(k) index record K221420. Device: AlphaID™ At Home Genetic Health Risk Service. Applicant as listed: Progenika Biopharma S.A., A Grifols Company. Decision date: 2022-10-27.

OtherU.S. Food and Drug Administration (FDA)2022-10-27

Source

"device_name": "AlphaID™ At Home Genetic Health Risk Service"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K221420.

Device name: AlphaID™ At Home Genetic Health Risk Service. Applicant as listed: Progenika Biopharma S.A., A Grifols Company.

Decision date: 2022-10-27. Decision wording: Substantially Equivalent.

Product code: PTA. Regulation: 21 CFR 866.5950. Medical specialty: Immunology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.